title: MUTZ-3 derived Langerhans cells in human skin equivalents show differential migration and phenotypic plasticity after allergen or irritant exposure.
abstract: After allergen or irritant exposure, Langerhans cells (LC) undergo phenotypic changes and exit the epidermis. In this study we describe the unique ability of MUTZ-3 derived Langerhans cells (MUTZ-LC) to display similar phenotypic plasticity as their primary counterparts when incorporated into a physiologically relevant full-thickness skin equivalent model (SE-LC). We describe differences and similarities in the mechanisms regulating LC migration and plasticity upon allergen or irritant exposure. The skin equivalent consisted of a reconstructed epidermis containing primary differentiated keratinocytes and CD1a(+) MUTZ-LC on a primary fibroblast-populated dermis. Skin equivalents were exposed to a panel of allergens and irritants. Topical exposure to sub-toxic concentrations of allergens (nickel sulfate, resorcinol, cinnamaldehyde) and irritants (Triton X-100, SDS, Tween 80) resulted in LC migration out of the epidermis and into the dermis. Neutralizing antibody to CXCL12 blocked allergen-induced migration, whereas anti-CCL5 blocked irritant-induced migration. In contrast to allergen exposure, irritant exposure resulted in cells within the dermis becoming CD1a(-)/CD14(+)/CD68(+) which is characteristic of a phenotypic switch of MUTZ-LC to a macrophage-like cell in the dermis. This phenotypic switch was blocked with anti-IL-10. Mechanisms previously identified as being involved in LC activation and migration in native human skin could thus be reproduced in the in vitro constructed skin equivalent model containing functional LC. This model therefore provides a unique and relevant research tool to study human LC biology in situ under controlled in vitro conditions, and will provide a powerful tool for hazard identification, testing novel therapeutics and identifying new drug targets.
authors.affiliation: Department of Dermatology, VU University Medical Center, Amsterdam, The Netherlands.
authors.forename: Ilona J
authors.initials: IJ
authors.lastname: Kosten
authors.affiliation: Department of Dermatology, VU University Medical Center, Amsterdam, The Netherlands.
authors.forename: Sander W
authors.initials: SW
authors.lastname: Spiekstra
authors.affiliation: Department of Dermatology Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
authors.forename: Tanja D
authors.initials: TD
authors.lastname: de Gruijl
authors.affiliation: Department of Dermatology, VU University Medical Center, Amsterdam, The Netherlands; Department of Oral Cell Biology, Academic Center for Dentistry (ACTA), Amsterdam, The Netherlands. Electronic address: s.gibbs@acta.nl.
authors.forename: Susan
authors.initials: S
authors.lastname: Gibbs
mesh_terms: D000485:Allergens / Q000633:toxicity*; D015415:Biomarkers / Q000378:metabolism; D002454:Cell Differentiation / Q000187:drug effects*; D002460:Cell Line; D002465:Cell Movement / Q000187:drug effects*; D018925:Chemokines / Q000378:metabolism; D018920:Coculture Techniques; D004817:Epidermis / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007509:Irritants / Q000633:toxicity*; D015603:Keratinocytes / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D007801:Langerhans Cells / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D010641:Phenotype
chemical_list: D000485:Allergens; D015415:Biomarkers; D018925:Chemokines; D007509:Irritants
keywords: Allergen; Chemokine; Irritant; Langerhans cell; Macrophage; Skin equivalent